Activity of BMS284756 (T-3811) tested against anaerobic bacteria, Campylobacter jejuni, Helicobacter pylori and Legionella spp.
- 31 May 2001
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 40 (1-2), 45-49
- https://doi.org/10.1016/s0732-8893(01)00247-4
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Comparative Antianaerobic Activity of BMS 284756Antimicrobial Agents and Chemotherapy, 2001
- In vitro activity of new quinolones against Clostridium difficile.Journal of Antimicrobial Chemotherapy, 2001
- Antibacterial Spectrum of a Novel Des-Fluoro(6) Quinolone, BMS-284756Antimicrobial Agents and Chemotherapy, 2000
- In vitro antibacterial spectrum of a new broad-spectrum 8-methoxy fluoroquinolone, gatifloxacinJournal of Antimicrobial Chemotherapy, 2000
- In vitro activity of gatifloxacin tested against anaerobic bacteria by reference agar dilution and Etest methodsClinical Microbiology & Infection, 1999
- Characteristics and trends in macrolide resistance among Helicobacter pylori strains isolated in Bulgaria over four yearsDiagnostic Microbiology and Infectious Disease, 1999
- Comparative antimicrobial activity of gatifloxacin tested against Campylobacter jejuni including fluoroquinolone-resistant clinical isolatesDiagnostic Microbiology and Infectious Disease, 1999
- In-vitro activities of gatifloxacin, sparfloxacin and trovafloxacin against 103 strains of Legionella spp.Journal of Antimicrobial Chemotherapy, 1998
- In-vitro activity of trovafloxacin, a new fluoroquinolone, against recent clinical isolatesJournal of Antimicrobial Chemotherapy, 1997
- In vitro activity of metronidazole against Helicobacter pylori as determined by agar dilution and agar diffusionAntimicrobial Agents and Chemotherapy, 1991